{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:00:24Z","timestamp":1772650824795,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The lack of sufficient specificity and sensitivity among conventional cancer biomarkers, such as prostate specific antigen (PSA) for prostate cancer has been widely recognized after several decades of clinical implications. Autoantibodies (autoAb) among others are being extensively investigated as potential substitute markers, but remain elusive. One major obstacle is the lack of a sensitive and multiplex approach for quantifying autoAb against a large panel of clinically relevant tumor-associated antigens (TAA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To circumvent preparation of phage lysates and purification of recombinant proteins, we identified B cell epitopes from a number of previously defined prostate cancer-associated antigens (PCAA). Peptide epitopes from cancer\/testis antigen NY-ESO-1, XAGE-1b, SSX-2,4, as well as prostate cancer overexpressed antigen AMACR, p90 autoantigen, and LEDGF were then conjugated with seroMAP microspheres to allow multiplex measurement of autoAb present in serum samples. Moreover, simultaneous quantification of autoAb plus total PSA was achieved in one reaction, and termed the \"A+PSA\" assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Peptide epitopes from the above 6 PCAA were identified and confirmed that autoAb against these peptide epitopes reacted specifically with the full-length protein. A pilot study was conducted with the A+PSA assay using pre-surgery sera from 131 biopsy-confirmed prostate cancer patients and 121 benign prostatic hyperplasia and\/or prostatitis patients. A logistic regression-based A+PSA index was found to enhance sensitivities and specificities over PSA alone in distinguishing prostate cancer from nonmalignant cases. The A+PSA index also reduced false positive rate and improved the area under a receiver operating characteristic curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The A+PSA assay represents a novel platform that integrates autoAb signatures with a conventional cancer biomarker, which may aid in the diagnosis and prognosis of prostate cancer and others.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-9-43","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T18:20:27Z","timestamp":1303496427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases"],"prefix":"10.1186","volume":"9","author":[{"given":"Chong","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G","family":"Haw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Kalbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monty","family":"Liong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubio R","family":"Punzalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard S","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan J","family":"Pantuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de la Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mukouyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0952-7915(97)80053-2","volume":"9","author":"U Sahin","year":"1997","unstructured":"Sahin U, Tureci O, Pfreundschuh M: Serological identification of human tumor antigens. Curr Opin Immunol. 1997, 9: 709-716. 10.1016\/S0952-7915(97)80053-2.","journal-title":"Curr Opin Immunol"},{"key":"716_CR2","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1056\/NEJMe058157","volume":"353","author":"OJ Finn","year":"2005","unstructured":"Finn OJ: Immune response as a biomarker for cancer detection and a lot more. N Engl J Med. 2005, 353: 1288-1290. 10.1056\/NEJMe058157.","journal-title":"N Engl J Med"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0046-8177(03)00268-5","volume":"34","author":"Z Jiang","year":"2003","unstructured":"Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG: Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. Hum Pathol. 2003, 34: 792-796. 10.1016\/S0046-8177(03)00268-5.","journal-title":"Hum Pathol"},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJMoa051931","volume":"353","author":"X Wang","year":"2005","unstructured":"Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG: Autoantibody signatures in prostate cancer. N Engl J Med. 2005, 353: 1224-1235. 10.1056\/NEJMoa051931.","journal-title":"N Engl J Med"},{"key":"716_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pros.20181","volume":"63","author":"FD Shi","year":"2005","unstructured":"Shi FD, Zhang JY, Liu D, Rearden A, Elliot M, Nachtsheim D, Daniels T, Casiano CA, Heeb MJ, Chan EK, Tan EM: Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate. 2005, 63: 252-258. 10.1002\/pros.20181.","journal-title":"Prostate"},{"key":"716_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pros.20112","volume":"62","author":"T Daniels","year":"2005","unstructured":"Daniels T, Zhang J, Gutierrez I, Elliot ML, Yamada B, Heeb MJ, Sheets SM, Wu X, Casiano CA: Antinuclear autoantibodies in prostate cancer: immunity to LEDGF\/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate. 2005, 62: 14-26. 10.1002\/pros.20112.","journal-title":"Prostate"},{"key":"716_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1084\/jem.187.8.1349","volume":"187","author":"E Stockert","year":"1998","unstructured":"Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ: A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med. 1998, 187: 1349-1354. 10.1084\/jem.187.8.1349.","journal-title":"J Exp Med"},{"key":"716_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3835(99)00385-7","volume":"150","author":"MJ Scanlan","year":"2000","unstructured":"Scanlan MJ, Altorki NK, Gure AO, Williamson B, Jungbluth A, Chen YT, Old LJ: Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett. 2000, 150: 155-164. 10.1016\/S0304-3835(99)00385-7.","journal-title":"Cancer Lett"},{"key":"716_CR9","first-page":"441","volume":"1","author":"KA Egland","year":"2002","unstructured":"Egland KA, Kumar V, Duray P, Pastan I: Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Mol Cancer Ther. 2002, 1: 441-450.","journal-title":"Mol Cancer Ther"},{"key":"716_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","volume":"222","author":"M Johansson","year":"2008","unstructured":"Johansson M, Denardo DG, Coussens LM: Polarized immune responses differentially regulate cancer development. Immunol Rev. 2008, 222: 145-154. 10.1111\/j.1600-065X.2008.00600.x.","journal-title":"Immunol Rev"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD: The Immunobiology of Cancer Immunosurveillance and Immunoediting. Immunity. 2004, 21: 137-148. 10.1016\/j.immuni.2004.07.017.","journal-title":"Immunity"},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djp132","volume":"101","author":"MG Bouwhuis","year":"2009","unstructured":"Bouwhuis MG, Suciu S, Collette S, Aamdal S, Kruit WH, Bastholt L, Stierner U, Sales F, Patel P, Punt CJ, Hernberg M, Spatz A, ten Hagen TL, Hansson J, Eggermont AM: Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon. J Natl Cancer Inst. 2009, 101: 869-877. 10.1093\/jnci\/djp132.","journal-title":"J Natl Cancer Inst"},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-07-4782","volume":"14","author":"T Sittler","year":"2008","unstructured":"Sittler T, Zhou J, Park J, Yuen NK, Sarantopoulos S, Mollick J, Salgia R, Giobbie-Hurder A, Dranoff G, Hodi FS: Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity. Clin Cancer Res. 2008, 14: 3896-3905. 10.1158\/1078-0432.CCR-07-4782.","journal-title":"Clin Cancer Res"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","volume":"70","author":"L Sabater","year":"2008","unstructured":"Sabater L, Titulaer M, Saiz A, Verschuuren J, Gure AO, Graus F: SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology. 2008, 70: 924-928. 10.1212\/01.wnl.0000281663.81079.24.","journal-title":"Neurology"},{"key":"716_CR15","first-page":"136","volume":"12","author":"J-Y Zhang","year":"2003","unstructured":"Zhang J-Y, Casiano CA, Peng X-X, Koziol JA, Chan EKL, Tan EM: Enhancement of Antibody Detection in Cancer Using Panel of Recombinant Tumor-associated Antigens. Cancer Epidemiol Biomarkers Prev. 2003, 12: 136-143.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.10900","volume":"104","author":"B Stone","year":"2003","unstructured":"Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH: Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer. 2003, 104: 73-84. 10.1002\/ijc.10900.","journal-title":"Int J Cancer"},{"key":"716_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-2478(02)00209-2","volume":"85","author":"MA Lagarkova","year":"2003","unstructured":"Lagarkova MA, Koroleva EP, Kuprash DV, Boitchenko VE, Kashkarova UA, Nedospasov SA, Shebzukhov YV: Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). Immunol Lett. 2003, 85: 71-74. 10.1016\/S0165-2478(02)00209-2.","journal-title":"Immunol Lett"},{"key":"716_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ijc.20716","volume":"114","author":"G Zeng","year":"2005","unstructured":"Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbins PF, Dubinett SM, de Kernion JB, Belldegrun AS: Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer. 2005, 114: 268-273. 10.1002\/ijc.20716.","journal-title":"Int J Cancer"},{"key":"716_CR19","first-page":"22","volume":"3","author":"H Liu","year":"2005","unstructured":"Liu H, Li G, Cumberland WG, Wu T: Testing Statistical Significance of the Area under a Receiving Operating Characteristics Curve for Repeated Measures Design with Bootstrapping. Journal of Data Science. 2005, 3: 22-","journal-title":"Journal of Data Science"},{"key":"716_CR20","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/pros.20665","volume":"67","author":"JA Dubovsky","year":"2007","unstructured":"Dubovsky JA, McNeel DG: Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor. Prostate. 2007, 67: 1781-1790. 10.1002\/pros.20665.","journal-title":"Prostate"},{"key":"716_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1348-0421.2005.tb03751.x","volume":"49","author":"F Koizumi","year":"2005","unstructured":"Koizumi F, Noguchi Y, Saika T, Nakagawa K, Sato S, Eldib AM, Nasu Y, Kumon H, Nakayama E: XAGE-1 mRNA expression in prostate cancer and antibody response in patients. Microbiol Immunol. 2005, 49: 471-476.","journal-title":"Microbiol Immunol"},{"key":"716_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1158\/1055-9965.EPI-10-0007","volume":"19","author":"LJ Sokoll","year":"2010","unstructured":"Sokoll LJ, Sanda MG, Feng Z, Kagan J, Mizrahi IA, Broyles DL, Partin AW, Srivastava S, Thompson IM, Wei JT, Zhang Z, Chan DW: A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev. 2010, 19: 1193-1200. 10.1158\/1055-9965.EPI-10-0007.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"716_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","volume":"68","author":"B Laxman","year":"2008","unstructured":"Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM: A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008, 68: 645-649. 10.1158\/0008-5472.CAN-07-3224.","journal-title":"Cancer Res"},{"key":"716_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF03256217","volume":"10","author":"BK Zehentner","year":"2006","unstructured":"Zehentner BK, Secrist H, Zhang X, Hayes DC, Ostenson R, Goodman G, Xu J, Kiviat M, Kiviat N, Persing DH, Houghton RL: Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients. Mol Diagn Ther. 2006, 10: 397-403.","journal-title":"Mol Diagn Ther"},{"key":"716_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00345-010-0583-x","volume":"28","author":"C Prior","year":"2010","unstructured":"Prior C, Guillen-Grima F, Robles JE, Rosell D, Fernandez-Montero JM, Agirre X, Catena R, Calvo A: Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer. World J Urol. 2010, 28: 681-686. 10.1007\/s00345-010-0583-x.","journal-title":"World J Urol"},{"key":"716_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0022-5347(01)66974-X","volume":"154","author":"A Zisman","year":"1995","unstructured":"Zisman A, Zisman E, Lindner A, Velikanov S, Siegel YI, Mozes E: Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia. J Urol. 1995, 154: 1052-1055. 10.1016\/S0022-5347(01)66974-X.","journal-title":"J Urol"},{"key":"716_CR27","first-page":"175","volume":"10","author":"LS Marks","year":"2008","unstructured":"Marks LS, Bostwick DG: Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice. Rev Urol. 2008, 10: 175-181.","journal-title":"Rev Urol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:57:06Z","timestamp":1630504626000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-43","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,19]]},"assertion":[{"value":"9 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43"}}